I. Kiss
发表
B. Melichar,
Z. Bortlíček,
T. Buchler,
2017,
Targeted Oncology.
R. Vyzula,
L. Radová,
O. Slabý,
2017,
Oncogenesis.
R. Vyzula,
S. Ševčíková,
J. Šmarda,
2012,
International Journal of Colorectal Disease.
M. Ferracin,
M. Negrini,
R. Vyzula,
2015,
Oncotarget.
R. Vyzula,
A. Vasku,
L. Radová,
2012,
World journal of gastroenterology.
I. Kiss,
Klinika Komplexní,
2003
.
R. Vyzula,
T. Buchler,
P. Grell,
2019
.
P. Fabián,
M. Svoboda,
T. Macháčková,
2021,
In Vivo.
T. Pavlík,
B. Melichar,
L. Dušek,
2014,
BMC Cancer.
T. Pavlík,
B. Melichar,
L. Dušek,
2015,
BMC Gastroenterology.
A. Poprach,
B. Melichar,
L. Dušek,
2014,
Anticancer research.
A. Poprach,
T. Pavlík,
B. Melichar,
2015,
Targeted Oncology.
A. Poprach,
R. Vyzula,
M. Svoboda,
2012,
Cardiovascular Toxicology.
A. Poprach,
T. Pavlík,
B. Melichar,
2015,
European journal of cancer.
L. Dušek,
D. Krákorová,
I. Kiss,
2018,
Pathology & Oncology Research.
T. Buchler,
M. Kuhn,
I. Kiss,
2022,
Frontiers in Oncology.
A. Poprach,
Z. Bortlíček,
T. Buchler,
2016,
Anticancer research.
Administration of Nivolumab in Metastatic Renal Cell Cancer Following Treatment With mTOR Inhibitors
A. Poprach,
B. Melichar,
T. Buchler,
2021,
In Vivo.
A. Poprach,
B. Melichar,
T. Buchler,
2019,
Urologic oncology.
A. Poprach,
B. Melichar,
L. Dušek,
2014,
Urologic oncology.
M. Dostál,
V. Valek,
I. Kiss,
2022,
In Vivo.
B. Melichar,
T. Buchler,
Z. Linke,
2020
.
P. Wirapati,
S. Tejpar,
J. Bridgewater,
2017,
Annals of oncology : official journal of the European Society for Medical Oncology.
O. Slabý,
J. Nekvindová,
J. Laco,
2016,
Clinical chemistry and laboratory medicine.
A. Buliková,
J. Kissová,
M. Penka,
2014,
Anticancer research.
P. Wirapati,
S. Tejpar,
J. Bridgewater,
2017,
Annals of oncology : official journal of the European Society for Medical Oncology.
R. Vyzula,
O. Slabý,
M. Svoboda,
2012,
Cancer biomarkers : section A of Disease markers.
R. Vyzula,
A. Vasku,
L. Radová,
2012,
European Journal of Medical Research.
A. Poprach,
P. Fabián,
T. Kazda,
2021,
Medicine.
I. Berindan‐Neagoe,
O. Slabý,
M. Svoboda,
2020,
Cancer Genomics & Proteomics.
M. Penka,
Jirí Jarkovský,
J. Tomasek,
2011,
Hepato-gastroenterology.
T. Kazda,
D. Krákorová,
I. Kiss,
2021,
Medicine.
B. Vojtesek,
I. Kiss,
O. Bonczek,
2020,
Clinical genetics.
M. Svoboda,
T. Kazda,
D. Krákorová,
2022,
Cancers.
P. Grell,
I. Kiss,
S. Bořilová,
2020,
Onkologie.
M. Penka,
Jirí Jarkovský,
Z. Kala,
2011,
Neoplasma.
M. Penka,
J. Tomasek,
I. Kiss,
2011,
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.
R. Vyzula,
P. Fabián,
L. Radová,
2012,
Journal of cellular and molecular medicine.
P. Fabián,
L. Radová,
O. Slabý,
2021,
Pharmacological Reports.
O. Slabý,
Z. Kala,
I. Kiss,
2019,
Current genomics.
O. Slabý,
M. Svoboda,
T. Macháčková,
2019,
International journal of molecular sciences.
R. Vyzula,
L. Radová,
O. Slabý,
2018,
Cancer Epidemiology, Biomarkers & Prevention.
Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients
B. Melichar,
T. Buchler,
Z. Linke,
2020,
Cancer management and research.
A. Poprach,
B. Melichar,
T. Buchler,
2020,
Targeted Oncology.
A. Poprach,
B. Melichar,
L. Dušek,
2018,
Cancer management and research.
A. Poprach,
B. Melichar,
L. Dušek,
2018,
Targeted Oncology.
A. Poprach,
T. Pavlík,
B. Melichar,
2014,
Urologic oncology.
O. Slabý,
M. Svoboda,
T. Macháčková,
2020,
Cancers.
A. Poprach,
B. Melichar,
L. Dušek,
2017,
BMC Cancer.
I. Berindan‐Neagoe,
O. Slabý,
J. Srovnal,
2020,
Journal of clinical medicine.
A. Poprach,
Andrea Knight,
O. Slabý,
2020,
Diagnostics.
A. Poprach,
B. Melichar,
T. Buchler,
2020,
Cancers.
T. Kazda,
I. Kiss,
R. Demlova,
2020,
Medicine.
R. Vyzula,
P. Fabián,
L. Radová,
2016,
Carcinogenesis.
M. Penka,
Jirí Jarkovský,
Z. Kala,
2013,
Neoplasma.
P. Souček,
P. Anzenbacher,
P. Fabián,
2020,
Biochemical pharmacology.
O. Slabý,
M. Svoboda,
T. Kazda,
2021,
Frontiers in Oncology.
Zdenek Kala,
Marek Svoboda,
Vaclav Liska,
2016,
Cancer genomics & proteomics.
J. Vyskočil,
L. Zdražilová-Dubská,
I. Kiss,
2019,
International immunopharmacology.
V. Valek,
Z. Kala,
J. Petera,
2007,
European journal of radiology.
A. Poprach,
B. Melichar,
L. Dušek,
2017,
Clinical genitourinary cancer.
R. Vyzula,
T. Buchler,
P. Grell,
2020
.
R. Vyzula,
O. Slabý,
M. Svoboda,
2012,
Oncology.
A. Poprach,
T. Pavlík,
B. Melichar,
2016,
Drugs & Aging.
O. Slabý,
M. Svoboda,
T. Kazda,
2021,
Scientific Reports.
Z. Čermáková,
M. Mlnaříková,
I. Selingerová,
2021,
Annals of Oncology.
A. Benson,
J. Bridgewater,
C. Van Sant,
2016,
Clinical Cancer Research.
A. Poprach,
B. Melichar,
L. Dušek,
2017,
BMC Cancer.
The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers
M. Svoboda,
T. Kazda,
I. Kiss,
2023,
Scientific Reports.
E. Van Cutsem,
Huanyu Chen,
T. Bekaii-Saab,
2023,
Journal of Clinical Oncology.
J. Pánek,
V. Valek,
Z. Kala,
2010,
Gut and liver.
R. Vyzula,
P. Grell,
P. Fabián,
2021,
Therapeutic advances in medical oncology.
P. Karásek,
M. Hermanová,
O. Slabý,
2018,
Cancer Genomics & Proteomics.
L. Dušek,
R. Vyzula,
Jirí Jarkovský,
2006,
Neoplasma.
R. Vyzula,
P. Karásek,
M. Hermanová,
2015,
Diagnostic Pathology.
A. Poprach,
R. Vyzula,
M. Svoboda,
2012,
Cardiovascular Toxicology.
P. Wirapati,
S. Tejpar,
E. Maiello,
2017,
Annals of oncology : official journal of the European Society for Medical Oncology.
O. Slabý,
T. Macháčková,
T. Catela Ivković,
2023,
Clinical chemistry and laboratory medicine.
R. Vyzula,
P. Grell,
P. Fabián,
2023,
Cancers.
A. Poprach,
R. Vyzula,
P. Fabián,
2017,
Oncology letters.